Federal Court of Australia
FEDERAL COURT OF AUSTRALIA
Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd (No 2) [2013] FCA 279 Citation: Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd (No 2) [2013] FCA 279
Parties: BAYER PHARMA AKTIENGESELLSCHAFT and BAYER AUSTRALIA LIMITED ACN 000 138 714 v GENERIC HEALTH PTY LTD ACN 110 617 859 and LUPIN AUSTRALIA PTY LTD ACN 112 038 105
File number(s): NSD 236 of 2012
Judge: JAGOT J
Date of judgment: 4 April 2013
Catchwords: PATENTS – Validity – Infringement – Lack of inventive step – Obviousness – Manner of manufacture – Fair basing
Legislation: Patents Act 1990 (Cth) Therapeutic Goods Act 1989 (Cth)
Cases cited: Aktiebolaget Hassle v Alphapharm (2002) 212 CLR 411; [2002] HCA 59 Alpharpharm Pty Ltd v H Lundbeck A/S (2008) 76 IPR 618; (2008) FCA 559 Application of Tomlinson (1966) 363F 2d 928 Bayer Pharma Aktiengelsellschaft v Generic Health Pty Ltd [2013] FCA 226) Cancer Voices Australia v Myriad Genetics Inc [2013] FCA 65 Commissioner of Patents v Microcells Ltd (1959) 102 CLR 323 Lockwood Security Products Pty Ltd v Doric Products Pty Ltd (No 1) (2004) 217 CLR 274; [2004] HCA 58 National Research Development Corporation v Commissioner of Patents (1959) 102 CLR 252 Olin Mathieson Chemical Corporation v Biorex Laboratories Ltd [1970] RPC 157 Populin v HB Nominees Pty Ltd (1982) 41 ALR 471 Pfizer Overseas Pharmaceuticals v Eli Lilly & Co (2005) 5 ALR 416; [2005] FCAFC 224 Wellcome Foundation Ltd v VR Laboratories (Aust) Pty Ltd (1981) 148 CLR 262; [1981] HCA 12
We try to embed the page this law was scraped from. If the site blocks framing, you still get the link and a local excerpt.
Last checked with source on —
Checking whether the official page can be embedded…
Plain-English simplify of this law: a short summary, key points, and both sides of the argument. Generated on first view via Replicate, then cached. Vote on what helps your study.
No study brief is cached for this law yet. Sign up to generate a plain-English brief.
Sign up to generate